期刊文献+

MAPK/ERK信号通路调节K562细胞中mdr1基因的诱导性表达

The mitogen-activated protein kinase pathway regulates the induced expression of mdrl gene in K562 cells
原文传递
导出
摘要 目的观察多柔比星(doxombicin,DOX)诱导K562细胞mdr1基因表达过程中丝裂原活化蛋白激酶(mitogen—activated protein kinase,MAPK)/细胞外信号调节激酶(ERK)信号通路的作用,探讨mdr1基因的转录调控机制。方法多柔比星初始浓度为0.01μg/ml,诱导K562细胞24h后撤药继续培养至细胞状态恢复,加入多柔比星继续诱导24h,浓度增加为0.02μg/ml。依上述方法多柔比星浓度逐渐增加,直至0.05μg/ml。收集DOX浓度为0.01、0.03和0.05μg/ml时的细胞。RT—PCR检测mdrl基因表达,流式细胞仪检测mdrl基因编码的P糖蛋白(P—gP)的表达,Western blot检测ERK活化情况。MAPK的抑制剂PD98059预处理K562细胞1h后与多柔比星共同作用,逆转录(RT)-PCR和流式细胞仪分别检测mdr1基因和P—gP的表达情况。结果经多柔比星作用后K562细胞中ERK磷酸化增强,同时mdr1基因转录上调,及其蛋白产物P—gP的表达也增加,当多柔比星浓度为0.05μg/ml时两者的表达均增加了5倍之多。而用PD98059预处理细胞后能明显抑制多柔比星诱导mdr1基因转录和蛋白表达,多柔比星浓度为0.03μg/ml时PD98059对mdr1基因表达的抑制率为(74.1±0.11)%,多柔比星浓度为0.05μg/ml时抑制率为(70.2±0.14)%。结论多柔比星能够诱导K562细胞mdr1基因表达,同时激活MAPK/ERK信号通路,阻断ERK的活化能抑制mdr1基因的诱导性表达。 Objective To investigate the effect of mitogen-activated protein kinase(MAPK) pathway on the transcriptional expression of mdrl gene induced by doxornbicin ( DOX ) and study the transcription regulation of mdrl gene. Methods K562 cells were treated with DOX ( 0. 01 μg/ml ) with the initial concentration of 0. 01μg/ml for 24 hours, then change the culture media without DOX. K562 cells were cultured until the its status was recovered. Subsequently the cells were treated with DOX (0. 02μg/ml) for 24 hours again. The concentration of DOX was increased until 0. 05μg/ml by following the protocol above. K562 cells were collected at the concentration of 0. 01μg/ml, 0. 03μg/ml and 0. 05μg/ml DOX. Expression of mdrl gene were examined by reverse transcription-polymerase chain reaction (RT-PCR). Pglycoprotein (P-gp) was detected by flow cytometry. Western blot was performed to detect ERK and P-ERK. K562 cells were pretreated with MAPK inhibitor PD98059 for 1 hour, and then DOX was added. RT-PCR and FCM were used to detect the expression of rnclrl mRNA and P-gp. Results When K562 cells were exposured to DOX, the phosphorylation of ERK was increased, the mdrl gene was highly expressed as well as its corresponding protein P-gp. When the concentration of DOX was 0. 05μg/ml, the expression of mdrl gene and P-gp were increased over 5 fold. When K562 cells were pretreated with MAPK inhibitor PD98059, the expression of mdrl gene induced by DOX ( the concentration was 0. 03 μg/ml and 0. 05μg/ml ) was effectively inhibited by ( 74. 1±0. 11 ) % and ( 70. 2±0. 14 ) % respectively. Conclusions DOX could induce the expression of mdrl gene in K562 cells accompanied by the activation of MAPK/ERK pathway. The block of activation of ERK could inhibit the induced expression of mdrl gene.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2009年第11期1289-1293,共5页 Chinese Journal of Laboratory Medicine
基金 江苏省卫生重大课题基金资助项目(K2005017)
关键词 多药耐药蛋白质类 丝裂原活化蛋白激酶 细胞外信号调节MAP激酶类 Multidrug resistance-associated protein Mitogen-activated protein kinase Extracellular signal-regulated MAP kinases
  • 相关文献

参考文献12

  • 1Thompson N, Lyons J. Recent progress in targeting the Raf/ MEK/ERK pathway with inhibitors in cancer drug discovery. Curt Opin Pharmacol, 2005, 5 : 350-356.
  • 2Aisa Y, Miyakawa Y, Nakazato T, et al. Fucoidan induces apoptosis of human HS-suhan cells accompanied by activation of caspase-3 and down-regulation of ERK pathways. Am J Hematol, 2005, 78 : 7-14.
  • 3Zhou J, Liu M, Aneja R, et al. Reversal of P-glycoproteinmediated multidrug resistance in cancer cells by the c-Jun NH2- teriminal kinase. Cancer Res, 2006, 66:445-452.
  • 4Wartenberg M, Gronczynska S, Bekhite MM, et al. Regulation of the muhidrugresist ance transporter P-glycoprotein in multicellular prostate tumor spheroids by hyperthermia and reactive oxygen species. Int J Cancer, 2005, 113:229-240.
  • 5Barancik M, Bohacova V, Kvackajova J, etal. SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance. Eur J Pharm Sci, 2001 , 14:29-36.
  • 6Di Nicolantonio F, Knight LA, Glaysher S, et al. Ex vivo reversal of chemoresistance by tariquidar (XR9576). Anticancer Drugs, 2004, 15:861-869.
  • 7Robert J, Jarry C. Multidrugresist ance reversal agents. J ivied Chem, 2003, 46:4805-4817.
  • 8Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer, 2002, 2: 48-58.
  • 9Dent P, Jarvis WD, Birrer MJ, et al. The role of signaling by the p42/p44 mitogen-activated protein ( MAP ) kinase pathway: a potential route to radio-and chemo-sensitization of tumor cells resulting in the induction of apotosis and loss of clonogenicity. Leukemia, 1998, 12 : 1843-1850.
  • 10Katayama K, Yoshioka S, Tsukahara S, et al. Inhibition of the mitogen-activated protein kinase pathway results in the downregulation of P-glycoprotein. Mol Cancer Ther, 2007, 6:2092-2102.

二级参考文献8

  • 1Schinkei AH, Borst P. Multidrug resistance mediated by P-glycoproteins[J]. Semin Cancer Biol, 1991, 2(4): 213~226
  • 2Meijer GA, Schroeijers AB, Flens MJ, et al. Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis [J]. J Clin Pathol,1999, 52(6): 450~454
  • 3Chaudhary PM, Roninson IB. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs[J].J Natl Cancer Inst, 1993, 85(8): 632~639
  • 4Tomida A, Naito M, Tsuruo T. Acute Induction of adriamycinresistance in human colon carcinoma HT-29 cells exposed to a sublethal dose of adriamycin [J].JpnJ Cancer Res, 1995, 86(2):224~232
  • 5Chang F, Steelman LS, LeeJT, et al. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention[J]. Leukemia, 2003, 17(7): 1263~1293
  • 6Reddy KB, Nabba SM, Atanaskova N, et al. Role of MAP kinase in tumor progression and invasion [J]. Cancer Metastasis Rev,2003, 22(4): 395~403
  • 7Dent P, Jarvis WD, Birrer MJ, et al. The role of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway: a potential route to radio-and chemo-sensitization of tumor cells resulting in the induction of apotosis and loss of clonogenicity[J].Leukemia, 1998, 12(12): 1843~1850
  • 8Kisucka J, Barancik M, Bohacova V, et al. Reversal effect of specific inhibitors of extracellular-signal regulated protein kinase pathway on P-glycoprotein mediated vincristine resistance of L1210 cells[J]. Gen Physiol Biophys, 2001, 20(4): 439~444

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部